Disruption of maize kernel growth and development by heat stress (role of cytokinin/abscisic acid balance)
N Cheikh, RJ Jones - Plant physiology, 1994 - academic.oup.com
Temperature stress during kernel development affects maize (Zea mays L.) grain growth
and yield stability. Maize kernels (hybrid A619 x W64A) were cultured in vitro at 3 d after …
and yield stability. Maize kernels (hybrid A619 x W64A) were cultured in vitro at 3 d after …
Kernel sink capacity in maize: genotypic and maternal regulation
RJ Jones, BMN Schreiber, JA Roessler - Crop Science, 1996 - Wiley Online Library
Previous research has shown that kernel sink capacity, the potential of maize ( Zea mays L.)
kernels to achieve maximal mass, is established during the early stages of kernel …
kernels to achieve maximal mass, is established during the early stages of kernel …
[HTML][HTML] Abiraterone and increased survival in metastatic prostate cancer
Background Biosynthesis of extragonadal androgen may contribute to the progression of
castration-resistant prostate cancer. We evaluated whether abiraterone acetate, an inhibitor of …
castration-resistant prostate cancer. We evaluated whether abiraterone acetate, an inhibitor of …
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind …
Background Abiraterone acetate improved overall survival in metastatic castration-resistant
prostate cancer at a preplanned interim analysis of the COU-AA-301 double-blind, placebo-…
prostate cancer at a preplanned interim analysis of the COU-AA-301 double-blind, placebo-…
[HTML][HTML] Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
…, DP Dearnaley, S Gillessen, C Gilson, RJ Jones… - The Lancet, 2018 - thelancet.com
Background Based on previous findings, we hypothesised that radiotherapy to the prostate
would improve overall survival in men with metastatic prostate cancer, and that the benefit …
would improve overall survival in men with metastatic prostate cancer, and that the benefit …
[HTML][HTML] Survival with newly diagnosed metastatic prostate cancer in the “docetaxel era”: data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08 …
Background Prostate cancer (PCa) is the second most common disease among men
worldwide. It is important to know survival outcomes and prognostic factors for this disease. …
worldwide. It is important to know survival outcomes and prognostic factors for this disease. …
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
…, T Eisen, S Broderick, WM Stadler, RJ Jones… - The Lancet …, 2016 - thelancet.com
Background Non-clear cell renal cell carcinomas are histologically and genetically diverse
kidney cancers with variable prognoses, and their optimum initial treatment is unknown. We …
kidney cancers with variable prognoses, and their optimum initial treatment is unknown. We …
Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling
E Avizienyte, AW Wyke, RJ Jones, GW McLean… - Nature cell …, 2002 - nature.com
Although Src expression and activity are often elevated in colon cancer 1, 2, 3, the precise
consequences of overexpression of the non-catalytic Src homology (SH) domains, or …
consequences of overexpression of the non-catalytic Src homology (SH) domains, or …
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
…, U De Giorgi, JY Joung, PCC Fong, E Voog, RJ Jones… - The Lancet, 2023 - thelancet.com
Background Co-inhibition of poly(ADP-ribose) polymerase (PARP) and androgen receptor
activity might result in antitumour efficacy irrespective of alterations in DNA damage repair …
activity might result in antitumour efficacy irrespective of alterations in DNA damage repair …
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration …
Background Bone metastases are a major cause of morbidity in metastatic castration-resistant
prostate cancer. Abiraterone acetate potently disrupts intracrine androgen receptor …
prostate cancer. Abiraterone acetate potently disrupts intracrine androgen receptor …